See more : Bruush Oral Care Inc. (BRSH) Income Statement Analysis – Financial Results
Complete financial analysis of Metropolis Healthcare Limited (METROPOLIS.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Metropolis Healthcare Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Rubis (RBSFY) Income Statement Analysis – Financial Results
- Enplas Corporation (6961.T) Income Statement Analysis – Financial Results
- TAT Technologies Ltd. (TATT) Income Statement Analysis – Financial Results
- Worldline SA (WRDLY) Income Statement Analysis – Financial Results
- Innovent Biologics, Inc. (1801.HK) Income Statement Analysis – Financial Results
Metropolis Healthcare Limited (METROPOLIS.BO)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Website: https://www.metropolisindia.com
About Metropolis Healthcare Limited
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, and diagnosis of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.08B | 11.48B | 12.28B | 9.98B | 8.56B | 7.60B | 6.44B | 5.45B | 4.75B | 4.55B | 3.88B |
| Cost of Revenue | 6.26B | 2.64B | 2.87B | 2.60B | 2.14B | 1.81B | 1.53B | 1.40B | 1.29B | 1.35B | 1.18B |
| Gross Profit | 5.81B | 8.85B | 9.41B | 7.38B | 6.42B | 5.79B | 4.90B | 4.04B | 3.46B | 3.20B | 2.71B |
| Gross Profit Ratio | 48.13% | 77.03% | 76.61% | 73.92% | 75.05% | 76.12% | 76.17% | 74.25% | 72.80% | 70.27% | 69.72% |
| Research & Development | 0.00 | 87.45M | 89.08M | 68.31M | 80.92M | 69.80M | 65.25M | 41.10M | 43.40M | 51.26M | 56.86M |
| General & Administrative | 3.60B | 1.32B | 1.47B | 840.22M | 698.27M | 602.99M | 526.93M | 433.76M | 401.15M | 0.00 | 0.00 |
| Selling & Marketing | 327.74M | 261.56M | 269.30M | 131.25M | 112.63M | 143.49M | 123.36M | 80.25M | 87.86M | 0.00 | 0.00 |
| SG&A | 3.93B | 1.59B | 1.74B | 971.47M | 810.90M | 746.49M | 650.30M | 514.01M | 489.01M | 1.18B | 932.47M |
| Other Expenses | 0.00 | 45.23M | 4.35M | 20.10M | 10.01M | 2.36M | 3.48M | 11.27M | 5.66M | 0.00 | 0.00 |
| Operating Expenses | 3.30B | 6.76B | 6.52B | 4.91B | 4.65B | 3.92B | 3.24B | 2.66B | 2.33B | 2.20B | 1.75B |
| Cost & Expenses | 10.02B | 9.39B | 9.40B | 7.51B | 6.79B | 5.73B | 4.78B | 4.06B | 3.63B | 3.56B | 2.93B |
| Interest Income | 32.06M | 57.08M | 111.48M | 93.01M | 59.00M | 34.65M | 23.69M | 50.14M | 16.00M | 11.69M | 3.77M |
| Interest Expense | 278.35M | 268.02M | 197.42M | 77.82M | 83.45M | 5.31M | 12.08M | 3.87M | 7.98M | 0.00 | 0.00 |
| Depreciation & Amortization | 944.68M | 892.16M | 632.23M | 459.45M | 392.67M | 200.66M | 190.18M | 172.27M | 166.41M | 198.18M | 158.88M |
| EBITDA | 2.97B | 3.08B | 3.81B | 3.01B | 2.21B | 2.10B | 1.85B | 1.76B | 1.42B | 1.17B | 1.07B |
| EBITDA Ratio | 24.59% | 26.39% | 29.31% | 29.83% | 25.64% | 27.21% | 28.55% | 30.23% | 28.34% | 25.78% | 27.47% |
| Operating Income | 2.03B | 2.14B | 2.96B | 2.52B | 1.78B | 1.88B | 1.65B | 1.38B | 1.12B | 975.92M | 907.76M |
| Operating Income Ratio | 16.84% | 18.63% | 24.08% | 25.22% | 20.81% | 24.67% | 25.71% | 25.41% | 23.55% | 21.43% | 23.38% |
| Total Other Income/Expenses | -287.10M | -263.91M | -2.64B | -73.27M | -85.71M | -3.77M | -21.57M | -732.34M | 147.85M | 29.47M | 36.35M |
| Income Before Tax | 1.75B | 1.88B | 2.93B | 2.44B | 1.69B | 1.87B | 1.64B | 1.60B | 1.28B | 1.01B | 949.40M |
| Income Before Tax Ratio | 14.46% | 16.33% | 23.88% | 24.49% | 19.72% | 24.54% | 25.43% | 29.36% | 26.82% | 22.19% | 24.45% |
| Income Tax Expense | 462.33M | 441.09M | 786.65M | 609.74M | 411.81M | 629.39M | 518.39M | 526.64M | 455.67M | 331.24M | 323.16M |
| Net Income | 1.28B | 1.43B | 2.14B | 1.83B | 1.27B | 1.20B | 1.04B | 1.02B | 767.96M | 609.75M | 565.58M |
| Net Income Ratio | 10.58% | 12.44% | 17.44% | 18.35% | 14.88% | 15.81% | 16.20% | 18.66% | 16.15% | 13.39% | 14.57% |
| EPS | 24.95 | 27.91 | 41.87 | 35.97 | 25.36 | 24.06 | 21.00 | 20.48 | 15.25 | 11.89 | 11.03 |
| EPS Diluted | 24.87 | 27.81 | 41.66 | 35.79 | 25.25 | 24.02 | 20.89 | 20.35 | 15.14 | 11.89 | 11.03 |
| Weighted Avg Shares Out | 51.23M | 51.20M | 51.16M | 50.90M | 50.21M | 49.93M | 49.63M | 49.63M | 50.36M | 51.30M | 51.29M |
| Weighted Avg Shares Out (Dil) | 51.39M | 51.37M | 51.41M | 51.16M | 50.43M | 50.03M | 49.91M | 49.95M | 50.72M | 51.29M | 51.29M |
Source: https://incomestatements.info
Category: Stock Reports